Annual Cash & Cash Equivalents
$15.40 K
-$109.10 K-87.63%
December 1, 2023
Summary
- As of February 9, 2025, BLAC annual cash & cash equivalents is $15.40 thousand, with the most recent change of -$109.10 thousand (-87.63%) on December 1, 2023.
- During the last 3 years, BLAC annual cash & cash equivalents has fallen by -$47.30 thousand (-75.44%).
- BLAC annual cash & cash equivalents is now -87.63% below its all-time high of $124.50 thousand, reached on December 1, 2022.
Performance
BLAC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$12.20 K
-$106.90 K-89.76%
September 1, 2024
Summary
- As of February 9, 2025, BLAC quarterly cash and cash equivalents is $12.20 thousand, with the most recent change of -$106.90 thousand (-89.76%) on September 1, 2024.
- Over the past year, BLAC quarterly cash and cash equivalents has stayed the same.
- BLAC quarterly cash and cash equivalents is now -96.50% below its all-time high of $348.80 thousand, reached on March 1, 2023.
Performance
BLAC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BLAC Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -87.6% | 0.0% |
3 y3 years | -75.4% | 0.0% |
5 y5 years | -75.4% | 0.0% |
BLAC Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -87.6% | +220.8% | -96.5% | +916.7% |
5 y | 5-year | -87.6% | +220.8% | -96.5% | +916.7% |
alltime | all time | -87.6% | +220.8% | -96.5% | +916.7% |
Bellevue Life Sciences Acquisition Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $12.20 K(-89.8%) |
Jun 2024 | - | $119.10 K(+3208.3%) |
Mar 2024 | - | $3600.00(-76.6%) |
Dec 2023 | $15.40 K | $15.40 K(-73.4%) |
Sep 2023 | - | $58.00 K(+4733.3%) |
Jun 2023 | - | $1200.00(-99.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2023 | - | $348.80 K(+180.2%) |
Dec 2022 | $124.50 K(+2493.8%) | $124.50 K(+81.0%) |
Sep 2022 | - | $68.80 K(-7.3%) |
Jun 2022 | - | $74.20 K(+1445.8%) |
Dec 2021 | $4800.00(-92.3%) | $4800.00 |
Dec 2020 | $62.70 K | - |
FAQ
- What is Bellevue Life Sciences Acquisition annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition annual cash & cash equivalents year-on-year change?
- What is Bellevue Life Sciences Acquisition quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition quarterly cash and cash equivalents year-on-year change?
What is Bellevue Life Sciences Acquisition annual cash & cash equivalents?
The current annual cash & cash equivalents of BLAC is $15.40 K
What is the all time high annual cash & cash equivalents for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high annual cash & cash equivalents is $124.50 K
What is Bellevue Life Sciences Acquisition annual cash & cash equivalents year-on-year change?
Over the past year, BLAC annual cash & cash equivalents has changed by -$109.10 K (-87.63%)
What is Bellevue Life Sciences Acquisition quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BLAC is $12.20 K
What is the all time high quarterly cash and cash equivalents for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high quarterly cash and cash equivalents is $348.80 K
What is Bellevue Life Sciences Acquisition quarterly cash and cash equivalents year-on-year change?
Over the past year, BLAC quarterly cash and cash equivalents has changed by $0.00 (0.00%)